Natalia Dovlatova

The reversible P2Y12 antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function

Natalia Dovlatova, Joseph A. Jakubowski, Atsuhiro Sugidachi et al. · Journal of Thrombosis and Haemostasis · 2008 · 103 citations

Medicine, Pharmacology, Pharmacotherapy +17

DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease

Stan Heptinstall, David Iyú, Panagiotis Manolopoulos et al. · Platelets · 2008 · 68 citations

Medicine, Pharmacology, Pharmacotherapy +17

Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders

Natalia Dovlatova, Marie Lordkipanidzé, Gillian Lowe et al. · Journal of Thrombosis and Haemostasis · 2014 · 51 citations · Full text

Medicine, Hematology, Hemostasis +8

Detection of P2Y14 protein in platelets and investigation of the role of P2Y14 in platelet function in comparison with the EP3 receptor

Yanushi D. Wijeyeratne, Susan C. Fox, Panagiotis Manolopoulos et al. · Thrombosis and Haemostasis · 2008 · 29 citations

Medicine, Molecular Biology, Pharmacology +15

P2Y₁₂and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP

David Iyú, Jackie R. Glenn, Ann E. White et al. · Platelets · 2011 · 29 citations

Medicine, Pharmacology, Pharmacotherapy +17